Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 4
2006 2
2007 2
2008 5
2009 3
2010 2
2011 4
2013 1
2014 3
2015 4
2016 1
2017 3
2018 1
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Loss of hepatic Mboat7 leads to liver fibrosis.
Thangapandi VR, Knittelfelder O, Brosch M, Patsenker E, Vvedenskaya O, Buch S, Hinz S, Hendricks A, Nati M, Herrmann A, Rekhade DR, Berg T, Matz-Soja M, Huse K, Klipp E, Pauling JK, Wodke JA, Miranda Ackerman J, Bonin MV, Aigner E, Datz C, von Schönfels W, Nehring S, Zeissig S, Röcken C, Dahl A, Chavakis T, Stickel F, Shevchenko A, Schafmayer C, Hampe J, Subramanian P. Thangapandi VR, et al. Among authors: patsenker e. Gut. 2021 May;70(5):940-950. doi: 10.1136/gutjnl-2020-320853. Epub 2020 Jun 26. Gut. 2021. PMID: 32591434 Free PMC article.
Cannabinoids in liver diseases.
Patsenker E, Stickel F. Patsenker E, et al. Clin Liver Dis (Hoboken). 2016 Feb 26;7(2):21-25. doi: 10.1002/cld.527. eCollection 2016 Feb. Clin Liver Dis (Hoboken). 2016. PMID: 31041021 Free PMC article. Review. No abstract available.
Herbal hepatotoxicity.
Stickel F, Patsenker E, Schuppan D. Stickel F, et al. Among authors: patsenker e. J Hepatol. 2005 Nov;43(5):901-10. doi: 10.1016/j.jhep.2005.08.002. Epub 2005 Aug 25. J Hepatol. 2005. PMID: 16171893 Review. No abstract available.
Role of integrins in fibrosing liver diseases.
Patsenker E, Stickel F. Patsenker E, et al. Am J Physiol Gastrointest Liver Physiol. 2011 Sep;301(3):G425-34. doi: 10.1152/ajpgi.00050.2011. Epub 2011 Jun 9. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21659620 Free article. Review.
Metabolic signature of electrosurgical liver dissection.
von Schönfels W, von Kampen O, Patsenker E, Stickel F, Schniewind B, Hinz S, Ahrens M, Balschun K, Egberts JH, Richter K, Landrock A, Sipos B, Will O, Huebbe P, Schreiber S, Nothnagel M, Röcken C, Rimbach G, Becker T, Hampe J, Schafmayer C. von Schönfels W, et al. Among authors: patsenker e. PLoS One. 2013 Sep 13;8(9):e72022. doi: 10.1371/journal.pone.0072022. eCollection 2013. PLoS One. 2013. PMID: 24058442 Free PMC article.
Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.
Patsenker E, Stoll M, Millonig G, Agaimy A, Wissniowski T, Schneider V, Mueller S, Brenneisen R, Seitz HK, Ocker M, Stickel F. Patsenker E, et al. Mol Med. 2011;17(11-12):1285-94. doi: 10.2119/molmed.2011.00149. Epub 2011 Aug 19. Mol Med. 2011. PMID: 21863215 Free PMC article.
New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4.
Weder B, Schefer F, van Haaften WT, Patsenker E, Stickel F, Mueller S, Hutter S, Schuler C, Baebler K, Wang Y, Mamie C, Dijkstra G, de Vallière C, Imenez Silva PH, Wagner CA, Frey-Wagner I, Ruiz PA, Seuwen K, Rogler G, Hausmann M. Weder B, et al. Among authors: patsenker e. Inflamm Bowel Dis. 2021 Jul 28:izab140. doi: 10.1093/ibd/izab140. Online ahead of print. Inflamm Bowel Dis. 2021. PMID: 34320209
Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites.
von Schönfels W, Patsenker E, Fahrner R, Itzel T, Hinrichsen H, Brosch M, Erhart W, Gruodyte A, Vollnberg B, Richter K, Landrock A, Schreiber S, Brückner S, Beldi G, Sipos B, Becker T, Röcken C, Teufel A, Stickel F, Schafmayer C, Hampe J. von Schönfels W, et al. Among authors: patsenker e. Liver Int. 2015 Jan;35(1):207-14. doi: 10.1111/liv.12476. Epub 2014 Mar 6. Liver Int. 2015. PMID: 24484068
31 results